Annette Feussner
18Patents
6h-index
26Co-inventors
62Inventor score
Filing activity: Jan 21, 1999 → Sep 16, 2008
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6677440B1 | Process for the preparation in pure form of the protease activating blood clotting factor VII, its proenzyme or a mixture of both proteins by means of ion-exchange chromatography | Human Necessities | 13 | Expired |
| US7550567B2 | Fibrinogen purification | Human Necessities | 9 | Expired |
| US6528299B1 | Protease for activating clotting factor VII | Physics | 8 | Expired |
| US6906183B2 | Process for the separation of glycosylated and nonglycosylated proteins | Chemistry; Metallurgy | 7 | Expired |
| US7202065B2 | Stabilized liquid preparation of the protease which activates blood coagulation factor VII, or of its proenzyme | Human Necessities | 6 | Expired |
| US6670455B1 | Process for the preparation in pure form of the protease activating blood clotting VII, its proenzyme or a mixture of both proteins by means of affinity chromatography | Performing Operations; Transporting | 6 | Expired |
| US7153679B2 | Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis | Physics | 5 | Expired |
| US6831167B2 | Mutants of the factor VII-activating protease and detection methods using specific antibodies | Physics | 4 | Expired |
| US6911334B2 | Protease for activating clotting factor VII | Physics | 2 | Expired |
| US6479245B1 | Monoclonal antibody which is specific for activated coagulation factor VII, and its use | Chemistry; Metallurgy | 1 | Expired |
| US6835817B2 | Monoclonal antibody which is specific for activated coagulation factor VII, and its use | Chemistry; Metallurgy | 0 | Expired |
| US7442514B2 | Mutants of the factor VII-activating protease and detection methods using specific antibodies | Physics | 0 | Expired |
| US7803569B2 | Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis and methods of detecting FSAP and FSAP mutations | Physics | 0 | Active |
| US7879803B2 | Methods of treatment involving the protease for activating clotting factor VII | Physics | 0 | Active |
| US6573056B2 | Process for purifying factor VII and activated factor VII | Chemistry; Metallurgy | 0 | Expired |
| US7892842B2 | Procedure for the determination of the activity of the protease which activates factor VII from protein solutions | Emerging Cross-Sectional Technologies | 0 | Active |
| US7863009B2 | Mutants of the factor VII-activating protease and detection methods using specific antibodies | Physics | 0 | Active |
| US7829095B2 | Inhibitory monoclonal antibody against blood clotting factor VII-activating protease | Physics | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.